Patents by Inventor Robert Storms

Robert Storms has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8137914
    Abstract: The invention discloses the sequences of variant forms of alpha-fetoprotein transcripts that have been identified in human hemopoietic progenitors but not in differentiated mature cells. The variant forms of AFP (vAFP) cDNA sequences isolated from a multipotent hemopoietic cell line, K562, differ from the authentic AFP transcript, consisting of 15 exons, by lacking only exon 1. Instead of exon 1, vAFP transcripts use an additional one or two exons located in the 5?-untranslated region of the AFP gene. K562 expressed selectively vAFP, whereas a hepatocellular carcinoma cell line, HepG2, showed no detectable expression of vAFP. In normal adult tissues, vAFP transcripts is detected in the bone marrow, thymus and brain, but not the spleen, suggesting the expression occurs in normal hemopoietic progenitors. Moreover, CD34+Lin? hemopoietic stem/progenitor cells purified by flow cytometric sorting also express the variant transcripts.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: March 20, 2012
    Assignee: University of North Carolina at Chapel Hill
    Inventors: Hiroshi Kubota, Lola M. Reid, Robert Storms
  • Publication number: 20080131900
    Abstract: The invention discloses the sequences of variant forms of alpha-fetoprotein transcripts that have been identified in human hemopoietic progenitors but not in differentiated mature cells. The variant forms of AFP (vAFP) cDNA sequences isolated from a multipotent hemopoietic cell line, K562, differ from the authentic AFP transcript, consisting of 15 exons, by lacking only exon 1. Instead of exon 1, vAFP transcripts use an additional one or two exons located in the 5?-untranslated region of the AFP gene. K562 expressed selectively vAFP, whereas a hepatocellular carcinoma cell line, HepG2, showed no detectable expression of vAFP. In normal adult tissues, vAFP transcripts is detected in the bone marrow, thymus and brain, but not the spleen, suggesting the expression occurs in normal hemopoietic progenitors. Moreover, CD34+Lin? hemopoietic stem/progenitor cells purified by flow cytometric sorting also express the variant transcripts.
    Type: Application
    Filed: December 21, 2007
    Publication date: June 5, 2008
    Inventors: Hiroshi Kubota, Robert Storms, Lola Reid
  • Patent number: 7332589
    Abstract: The invention discloses the sequences of variant forms of alpha-fetoprotein transcripts that have been identified in human hemopoietic progenitors but not in differentiated mature cells. The variant forms of AFP (vAFP) cDNA sequences isolated from a multipotent hemopoietic cell line, K562, differ from the authentic AFP transcript, consisting of 15 exons, by lacking only exon 1. Instead of exon 1, vAFP transcripts use an additional one or two exons located in the 5?-untranslated region of the AFP gene. K562 expressed selectively vAFP, whereas a hepatocellular carcinoma cell line, HepG2, showed no detectable expression of vAFP. In normal adult tissues, vAFP transcripts is detected in the bone marrow, thymus and brain, but not the spleen, suggesting the expression occurs in normal hemopoietic progenitors. Moreover, CD34+Lin? hemopoietic stem/progenitor cells purified by flow cytometric sorting also express the variant transcripts.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: February 19, 2008
    Assignee: University of North Carolina at Chapel Hill
    Inventors: Hiroshi Kubota, Robert Storms, Lola M. Reid
  • Publication number: 20060051833
    Abstract: The present invention relates, in general, to stem cells, and in particular, to a method of isolating stem cells and to reagents suitable for use in such a method. The invention further relates to stem cell populations isolatable in accordance with the present method.
    Type: Application
    Filed: October 11, 2005
    Publication date: March 9, 2006
    Applicant: Duke University
    Inventors: Clayton Smith, Michael Colvin, Robert Storms, Susan Ludeman
  • Publication number: 20030148329
    Abstract: The invention discloses the sequences of variant forms of alpha-fetoprotein transcripts that have been identified in human hemopoietic progenitors but not in differentiated mature cells. The variant forms of AFP (vAFP) cDNA sequences isolated from a multipotent hemopoietic cell line, K562, differ from the authentic AFP transcript, consisting of 15 exons, by lacking only exon 1. Instead of exon 1, vAFP transcripts use an additional one or two exons located in the 5′-untranslated region of the AFP gene. K562 expressed selectively vAFP, whereas a hepatocellular carcinoma cell line, HepG2, showed no detectable expression of vAFP. In normal adult tissues, vAFP transcripts is detected in the bone marrow, thymus and brain, but not the spleen, suggesting the expression occurs in normal hemopoietic progenitors. Moreover, CD34+Lin− hemopoietic stem/progenitor cells purified by flow cytometric sorting also express the variant transcripts.
    Type: Application
    Filed: September 26, 2002
    Publication date: August 7, 2003
    Inventors: Hiroshi Kubota, Robert Storms, Lola Reid